By Andrew Nyholm
Wolman's Disease
Addition Symptoms
- Lipid build up in the spleen, bone marrow, liver, lymph nodes, small hormone-producing glands on top of each kidney, and/or the small intestines
- Most lysosomal storage disorders can be cured .
- Wolman's disease does not have a cure.
- The symptoms can be treated through the injection of vital nutrients.
- There has been only one successful long term treatments.
What is a Lysosomal Storage Disorder?
This is a disorder that affects how a lysosome functions.
- Enlarged liver and spleen
- Poor weight gain
- Low muscle gain
- Yellow tint to the skin and eyes
- Vomiting and diarrhea
- Developmental delay
- Anemia
- Poor absorption of nutrients
Discovery
Moshe Wolman discovered the disease in 1954 when studying other lysosomal storage disorders.
This disease is a lysosomal storage disorder
Additional Names
- Acid lipase deficiency
- Familial Xanthomatosis
- LAL deficiency
- LIPA deficiency
- Liposomal Acid Lipase Deficiency- Wolman Type
How does this type of disease work?
- A mutation occurs in the DNA
- The mutation causes a wrong formed enzyme
- That enzyme, if used in the Lyposome, cannot digest it's substrate.
- The substate builds up and clogs the lyposome.
- The cell does not recieve the products made by the enzyme.
What is a Lysosome?
-An organelle
- The digestive system of the cell.
-Uses enzymes to break apart molecules
-Has a Phospholipid bilayer
How is it Inherited?
- The mutated LIPA gene is an autosomal recessive gene.
- If both genes have the mutated, there is only a 5% chance of normal lysosome function.
What does mutation does Wolman's disease have?
- There are more than one mutations with the potential.
- The most common is a splice-site mutation.
- Replaces an Adenine with a Guanine
- Ends Polypeptide 24 amino acids short.
http://www.nature.com/bmt/journal/v26/n5/full/1702557a.html
http://ghr.nlm.nih.gov/gene/LIPA
http://ghr.nlm.nih.gov/condition/wolman-disease
http://www.disabled-world.com/disability/types/wolman-disease.php
Severity?
- Affects around 1 out of every 350,000 people
- The majority of infants with this disease do not live through their first year.